Piper Sandler Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $95
Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $98 to $95.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga